GET DAILY SIGNALSJBS N.V. (JBS): What to Expect from Q1 2026 Earnings
Key Takeaways
- Analysts expect Q1 2026 revenue of approximately $21.7 billion, reflecting modest growth amid protein demand.
- Consensus EPS estimate stands at $0.24, building on Q4 2025's $0.39 reported figure.
- Investors watching adjusted EBITDA margins, with focus on beef, pork, and poultry segments.
- Company guidance emphasizes capex at $2.4 billion for 2026, targeting leverage below 2.5x.
- Historical beats on revenue in recent quarters, though EPS mixed.
- Stock has shown resilience, up amid analyst upgrades ahead of report.
Understanding JBS Earnings and Their Importance
As the world's largest protein producer, JBS N.V. (JBS) manages a diversified portfolio that includes beef, pork, poultry, and processed foods across North America, Brazil, Australia, and Europe. After delivering record full-year 2025 revenue of $86 billion and net income of $2 billion, the upcoming Q1 2026 earnings report will provide insight into whether that momentum continues, particularly with tight U.S. cattle supplies and shifting global demand. From my perspective, this report is crucial for investors because it sheds light on operational efficiency, segment performance, and capital allocation decisions in a challenging commodity market. With shares trading near recent highs following the NYSE listing, the results could indicate if JBS can sustain its advantage across multiple proteins amid inflation and supply chain issues, which would also have implications for peers like Pilgrim's Pride.
Breaking Down the Earnings Expectations
Analysts are forecasting consensus revenue of $21.68 billion for Q1 2026 (January-March), a slight increase from prior periods, supported by volume growth in poultry and prepared foods that should offset headwinds in beef. The EPS consensus comes in at $0.24, with estimates ranging from $0.20 to $0.32—this follows Q4 2025's reported $0.39 against an expected $0.41. Key figures to watch include adjusted EBITDA, with margins projected around 7-8% in line with full-year trends, and leverage moving toward 2.5x or lower.
Looking back, the company has consistently beaten revenue expectations: Q4 2025 came in at $23.06 billion versus $22.6 billion anticipated (+15% YoY), and Q3 hit $22.6 billion (also a beat). EPS results have been more varied, with Q4 slightly missing the mark but full-year EPS rising 15% to $1.89. Stock reactions have been muted post-Q4 despite the revenue strength. I expect guidance to cover 2026 capex of $2.4 billion (split between expansion and maintenance) along with working capital requirements.
Market Sentiment Ahead of the Report
Investor sentiment heading into Q1 earnings feels cautiously optimistic. Recent analyst upgrades, such as Goldman Sachs' 'Buy' rating with a $48 price target, have pushed shares to 7-month highs. The overall consensus remains a Strong Buy, supported by the strong 2025 performance. That said, risks persist from tight U.S. beef supplies and elevated grain costs. Historically, beats have led to 5-10% upside, while misses could add pressure in this volatile environment. One thing that stands out to me is how resilient the stock has been amid these upgrades.
AI Screener: A Tool I Rely On for Analysis
In reviewing JBS, I also checked this using Tickeron’s AI Screener, which helps me filter stocks and ETFs based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of instruments with customizable filters like industry, market cap, technical indicators, price patterns, and performance metrics, making it easier to spot trade ideas, trending stocks, breakout candidates, and opportunities that might otherwise take hours to uncover manually. I find it particularly useful for comparing companies like JBS against sector peers efficiently.
Looking Ahead: Guidance and Factors to Track
Once earnings are out, attention will turn to reaffirmation of 2026 guidance. Management aims for EBITDA cash flow breakeven at $5.7 billion, factoring in $2.4 billion in capex and stable working capital—this should support free cash flow after 2025's $400 million generation.
Segment performance deserves close monitoring: Beef in North America continues to face cattle supply constraints into 2026, though exports from Australia and Brazil provide some balance. Upside potential lies in poultry (Pilgrim's Pride, Seara) and U.S. pork expansions, including new Iowa plants ramping up by 2027 to add $500-750 million in revenue at double-digit margins. Prepared foods have shown resilience with growth exceeding 25% in recent quarters.
Broader macro influences include commodity prices for grains and livestock, currency fluctuations (BRL/USD), and demand trends in China and the EU following reopenings. Leverage stood at 2.39x at Q4's end, providing room for buybacks and dividends ($1/share ex-May 18), with $7.4 billion in liquidity enabling opportunistic M&A. I'm watching Q2 trends closely as they will shape the full-year path toward revenue exceeding $88 billion.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
JBS saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for JBS moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 62 similar instances where the indicator exited the overbought zone. In 46 of the 62 cases the stock moved lower. This puts the odds of a downward move at 74%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
JBS broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for JBS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on JBS as a result. In 68 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for JBS just turned positive on November 04, 2026. Looking at past instances where JBS's MACD turned positive, the stock continued to rise in 28 of 43 cases over the following month. The odds of a continued upward trend are 65%.
JBS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for JBS crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 46%.
Following a +5.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where JBS advanced for three days, in 202 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.992) is normal, around the industry mean (6.914). P/E Ratio (11.664) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (8.458). JBS's Dividend Yield (0.321) is considerably higher than the industry average of (0.049). P/S Ratio (0.441) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. JBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry FoodMajorDiversified
Advertisement